A recent study using a mouse model of T acute lymphoblastic leukemia (T-ALL) identified Bcl2 as a direct target of TLX1 and NUP214-ABL1 oncogenes when both oncogenes were expressed in the same cells and suggested to be a potential therapeutic target in this context47. Here, BCL2 is linked to acute lymphoblastic leukemia.